Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Naas Lars Eivind Haugnes (Last) (First) (Middle) C/O BITDEER TECHNOLOGIES GROUP 08 KALLANG AVE, APERIA TOWER 1 #09-03/04 (Street) SINGAPORE U0 339509 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026	3. Issuer Name and Ticker or Trading Symbol Bitdeer Technologies Group [ BTDR ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Ordinary Shares	738,315	D
Class A Ordinary Shares	323,276	I	See footnote(1)
Class A Ordinary Shares	70,000	I	See footnote(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (right to buy)	(3)	01/01/2035	Class A Ordinary Shares	50,000	$21.67	D

Explanation of Responses:

1. These shares are held directly by Renol Invest AS. LEHN Invest 2 AS, an entity wholly owned by the Reporting Person, holds a 28.33% ownership interest in Renol Invest AS. The Reporting Person serves as the Chairman of the board of directors of Renol Invest AS and shares voting and dispositive power over the shares held by Renol Invest AS with the other directors. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended, the Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

2. These shares are held directly by LEHN Invest 2 AS. The Reporting Person is the sole shareholder and sole director of LEHN Invest 2 AS, and has sole voting and dispositive power over the shares held by LEHN Invest 2 AS.

3. 20% of the total shares subject to the option have become vested and exercisable on January 1, 2026, and remaining shares subject to the option shall become vested annually in equal installments of 20% on January 1st of each of the four subsequent years, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

	/s/ Lars Eivind Haugnes Naas	03/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.